With Vrylar’s new approval, there are now four atypicals antipsychotics with an indication in bipolar depression. Only two of these, however, are known to work in mania as well as depression. None of the atypicals stands out as the perfect choice for bipolar depression, but there are pros and cons to each that make them fitter better with certain patients.
Nicholas Rosenlicht, MDDr. Rosenlicht has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Recent trials cast doubt on prazosin’s role in PTSD, but there are reasons to doubt their results.
The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 1 CME credit.
Michael Posternak, MD.
Psychiatrist in private practice, Boston, MA.
Dr. Posternak has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
On March 5, 2019, the FDA approved esketamine (Spravato) nasal spray as add-on therapy to traditional antidepressant medications for treatment-resistant depression (TRD). In this article, I will describe the events that led to esketamine’s development, review the data submitted to the FDA, and discuss what the future might hold for esketamine.
Certain psychiatric treatments require both the healthcare provider and patient to enroll in a Risk Evaluation and Mitigation Strategy (REMS) program before they are administered. Here are links to enroll.
Rajnish Mago, MD Editor-in-Chief of Simple and Practical Mental Health and author of Side Effects of Psychiatric Medications: Prevention, Assessment, and ManagementDr. Mago has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Does ginger ale treat nausea? Not really, but Dr. Mago has some better ideas, and this interview is packed with new and practical ways to manage common side effects of psychiatric medications.
Joseph M. Pierre, MD.
Chief, Hospital Psychiatry Division at the VA West Los Angeles Healthcare Center. Clinical Professor in the Department of Psychiatry and Biobehavioral Sciences at UCLA.
Dr. Pierre has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
When a patient presents with auditory hallucinations (AH), are you likely to diagnose a psychotic disorder? If no other symptoms are present, would you recommend an antipsychotic? If you answered yes to either question, there’s some new research that may change your mind.
Talia Puzantian, PharmD, BCPP
Chris Aiken, MD.
Drs. Puzantian and Aiken have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Solriamfetol (Sunosi) was just approved for excessive daytime sleepiness in narcolepsy and sleep apnea, but it may have important psychiatric effects as well.
Talia Puzantian, PharmD, BCPP
Chris Aiken, MD
Drs. Puzantian and Aiken have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Every week of depression takes a toll on infant development, so this rapid-acting treatment fills a unique need. Here we review the clinical data and the pragmatics of getting patients connected with the therapy.